Articles les plus consultés

  • Les futures sur cac belle glissade < vix pas bon + 3%
        francis 13 Version sans publicité Marchés   Actualités   Analyses   Crypto   Fonds   Graphiques   Technique   Brokers   Outils   Portefe...
  • Nouvelles applications de médicaments avec des documents de soutien
    6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
  • pre-market
    Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium   14.95 + 39.07% 0,60K Mondialisation de l'Inde.   0,4800 + 18,52% 1,80K...
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation   51.30 + 10,73% 58.90K Staples Inc   9.25 + 6,81% 12,31K Delcat...
  • pre_market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath   0.1230 + 24,24% 196,67K Neos Therapeutics I.   10.50 +16.67% 34.36K Enpha...
  • les élus
    Citoyens_Français ‏   @citoyenneFrance     8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
  • pre-market
    Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In   5.32 + 32,34% 38.64K Enphase Energy Inc   0,938 + 17,57% 10,37K Delca...
  • bonjour.. approbations
    28 juin 2017 Nom du médicament et  numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
  • $ pré-market
    Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc   1,3900 +25,23% 3,55K Alibaba   139,95 +11,35% 1,40M MoSys...

jeudi 3 mai 2018

Adamas Reports First Quarter 2018 Financial Results

Adamas Reports First Quarter 2018 Financial Results
Posted by at Aucun commentaire:

Akcea Reports Financial Results and Highlights for First Quarter 2018

Akcea Reports Financial Results and Highlights for First Quarter 2018
Posted by at Aucun commentaire:

Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress

Preliminary Results from Quell Chronic Low Back Pain Study to be Presented at World Institute of Pain World Congress
Posted by at Aucun commentaire:

mercredi 2 mai 2018

Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab

Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab
Posted by at Aucun commentaire:

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections
Posted by at Aucun commentaire:

Achillion Reports First Quarter 2018 Financial Results and Management Transition

Achillion Reports First Quarter 2018 Financial Results and Management Transition
Posted by at Aucun commentaire:

IONTAS and aTen Therapeutics Announce Collaboration to Discover Therapeutic Oncology Leads | Business Wire

IONTAS and aTen Therapeutics Announce Collaboration to Discover Therapeutic Oncology Leads | Business Wire: IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by aTen Therapeutics.
Posted by at Aucun commentaire:
Inscription à : Articles (Atom)